Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines
Somatostatin analogs (SSA) are well-established antisecretory drugs in functionally active neuroendocrine tumors (NET). Two placebo-controlled trials have recently demonstrated significant improvement of progression-free survival under SSA treatment. Furthermore, somatostatin receptor (SSTR) overexp...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2018-04-01
|
| coleção: | Frontiers in Endocrinology |
| Assuntos: | |
| Acesso em linha: | http://journal.frontiersin.org/article/10.3389/fendo.2018.00146/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
